Phase Ib/II study of imprime PGG and pembrolizumab in patients with previously treated advanced non-small cell lung cancer (NSCLC): BTCRC LUN 15-017

Muhammad Furqan, Jyoti Malhotra, Ardaman Shergill, Li Liu, Sarah L. Mott, Mary M. Pasquinelli, Alicia Hulbert, Kathleen Kennedy, Lawrence Feldman